Sinotherapeutics Inc. A (688247) — Cash Flow Quality Index
Sinotherapeutics Inc. A (688247) has a Cash Flow Quality Index of 2.01x as of December 2025. Operating cash flow of CN¥95.33 Million exceeds net income of CN¥47.48 Million, indicating high earnings quality where cash backs reported profits. Explore 688247 cash generation efficiency to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Sinotherapeutics Inc. A Cash Flow Quality Index (2020–2025)
Historical Cash Flow Quality Index for Sinotherapeutics Inc. A across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 688247 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Sinotherapeutics Inc. A (2020–2025)
Year-by-year earnings quality comparison for Sinotherapeutics Inc. A. For live market cap and the full company financial profile, see Sinotherapeutics Inc. A market capitalisation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.01x | CN¥95.33 Million | CN¥47.48 Million | ▲ +96.9% |
| 2024 | 1.02x | CN¥130.23 Million | CN¥127.70 Million | ▲ +380.7% |
| 2023 | 0.21x | CN¥12.96 Million | CN¥61.07 Million | ▼ -73.1% |
| 2022 | 0.79x | CN¥73.18 Million | CN¥92.94 Million | ▼ -27.1% |
| 2021 | 1.08x | CN¥145.77 Million | CN¥134.92 Million | ▼ -40.0% |
| 2020 | 1.80x | CN¥210.04 Million | CN¥116.54 Million | — |